A dose-response study of the bioavailability of grape seed proanthocyanidin in rat and lipid-lowering effects of generated metabolites in HepG2 cells

Food Research International

Volumn 64, Issue , 2014, Pages 500-507

  Margalef, Maria ^a   Guerrero, Ligia ^a,b   Pons, Zara ^a   Bravo, Francisca Isabel ^a   Arola, Lluís ^a,c   Muguerza, Begoña ^a,c   Arola Arnal, Anna ^a  

^a UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^b Instituto Alpina   (Colombia)

^c TECNIO   (Spain)

Author keywords

Cholesterol; HPLC MS MS; Polyphenols; Proanthocyanidins; Triglycerides

Indexed keywords

BIOCHEMISTRY; BIOMOLECULES; BODY FLUIDS; CELLS; CHOLESTEROL; CYTOLOGY; LIPIDS; METABOLITES; PHYSIOLOGY; RATS;

CARDIO-VASCULAR DISEASE; DOSE-DEPENDENT MANNER; DOSE-RESPONSE STUDY; HPLC-MS/MS; LIPID-LOWERING EFFECTS; POLYPHENOLS; PROANTHOCYANIDINS; TRIGLYCERIDES; GRAPE SEEDS; HEP-G2 CELLS;

FLAVONOIDS; CHOLESTEROL;

EID: 84905649151     PISSN: 09639969     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.foodres.2014.07.019     Document Type: Article

References (38)

1. Arola-Arnal A., Oms-Oliu G., Crescenti A., Del Bas J.M., Ras M.R., Arola L., et al. Distribution of grape seed flavanols and their metabolites in pregnant rats and their fetuses. Molecular Nutrition & Food Research 2013, 57(10):1741-1752.
2. Auger C., Caporiccio B., Landrault N., Teissedre P.L., Laurent C., Cros G., et al. Red wine phenolic compounds reduce plasma lipids and apolipoprotein B and prevent early aortic atherosclerosis in hypercholesterolemic golden Syrian hamsters (Mesocricetus auratus). Journal of Nutrition 2002, 132(6):1207-1213.
3. Aura A.M. Microbial metabolism of dietary phenolic compounds in the colon. Phytochemistry Reviews 2008, 7(3):407-429.
4. Baselga-Escudero L., Arola-Arnal A., Pascual-Serrano A., Ribas-Latre A., Casanova E., Salvadó M.-J., et al. Chronic administration of proanthocyanidins or docosahexaenoic acid reverses the increase of miR-33a and miR-122 in dyslipidemic obese rats. PloS One 2013, 8(7):e69817.
5. Bladé C., Arola L., Salvadó M.J. Hypolipidemic effects of proanthocyanidins and their underlying biochemical and molecular mechanisms. Molecular Nutrition & Food Research 2010, 54(1):37-59.
6. Borriello A., Cucciolla V., Della Ragione F., Galletti P. Dietary polyphenols: Focus on resveratrol, a promising agent in the prevention of cardiovascular diseases and control of glucose homeostasis. Nutrition, Metabolism, and Cardiovascular Diseases 2010, 20(8):618-625.
7. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry 1976, 72(1):248-254.
8. Crozier A., Jaganath I.B., Clifford M.N. Dietary phenolics: Chemistry, bioavailability and effects on health. Natural Product Reports 2009, 26(8):1001-1043.
9. Del Bas J.M., Laos S., Caimari A., Crescenti A., Arola L. Detection of bioavailable peroxisome proliferator-activated receptor gamma modulators by a cell-based luciferase reporter system. Analytical Biochemistry 2012, 427:187-189.
10. Del Bas J.M., Ricketts M.L., Baiges I., Quesada H., Ardevol A., Salvadó M.J., et al. Dietary procyanidins lower triglyceride levels signaling through the nuclear receptor small heterodimer partner. Molecular Nutrition & Food Research 2008, 52(10):1172-1181.
11. Del Bas J.M., Ricketts M.L., Vaqué M., Sala E., Quesada H., Ardevol A., et al. Dietary procyanidins enhance transcriptional activity of bile acid-activated FXR in vitro and reduce triglyceridemia in vivo in a FXR-dependent manner. Molecular Nutrition & Food Research 2009, 53(7):805-814.
12. Del Rio D., Rodriguez-Mateos A., Spencer J.P.E., Tognolini M., Borges G., Crozier A. Dietary (poly)phenolics in human health: Structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxidants & Redox Signaling 2013, 18(14):1818-1892.
13. Guerrero L., Margalef M., Pons Z., Quiñones M., Arola L., Arola-Arnal A., et al. Serum metabolites of proanthocyanidin-administered rats decrease lipid synthesis in HepG2 cells. The Journal of Nutritional Biochemistry 2013, 24(12):2092-2099.
14. Gutierrez-Merino C., Lopez-Sanchez C., Lagoa R.K., Samhan-Arias A., Bueno C., Garcia-Martinez V. Neuroprotective actions of flavonoids. Current Medicinal Chemistry 2011, 18(8):1195-1212.
15. Hertog M.G., Kromhout D., Aravanis C., Blackburn H., Buzina R., Fidanza F., et al. Flavonoid intake and long-term risk of coronary heart disease and cancer in the seven countries study. Archives of Internal Medicine 1995, 155(4):381-386.
16. Hong S.J., Kim S.Il, Kwon S.M., Lee J.R., Chung B.C. Comparative study of concentration of isoflavones and lignans in plasma and prostatic tissues of normal control and benign prostatic hyperplasia. Yonsei Medical Journal 2002, 43(2):236-241.
17. Kay C.D. The future of flavonoid research. British Journal of Nutrition 2010, 104:S91-S95.
18. Kroon P.A., Clifford M.N., Crozier A., Day A.J., Donovan J.L., Manach C., et al. How should we assess the effects of exposure to dietary polyphenols in vitro?. American Journal of Clinical Nutrition 2004, 80(1):15-21.
19. Manach C., Scalbert A., Morand C., Rémésy C., Jiménez L. Polyphenols: Food sources and bioavailability. The American Journal of Clinical Nutrition 2004, 79(5):727-747.
20. Maubach J., Bracke M.E., Heyerick A., Depypere H.T., Serreyn R.F., Mareel M.M., et al. Quantitation of soy-derived phytoestrogens in human breast tissue and biological fluids by high-performance liquid chromatography. Journal of Chromatography B 2003, 784(1):137-144.
21. Monagas M., Urpi-Sarda M., Sánchez-Patán F., Llorach R., Garrido I., Gómez-Cordovés C., et al. Insights into the metabolism and microbial biotransformation of dietary flavan-3-ols and the bioactivity of their metabolites. Food & Function 2010, 1(3):233-253.
22. Nissen S.E., Tuzcu E.M., Schoenhagen P., Brown B.G., Ganz P., Vogel R.A., et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: A randomized controlled trial. JAMA: The Journal of the American Medical Association 2004, 291(9):1071-1080.
23. O'Leary K.A., Day A.J., Needs P.W., Mellon F.A., O'Brien N.M., Williamson G. Metabolism of quercetin-7- and quercetin-3-glucuronides by an in vitro hepatic model: The role of human β-glucuronidase, sulfotransferase, catechol-O-methyltransferase and multi-resistant protein 2 (MRP2) in flavonoid metabolism. Biochemical Pharmacology 2003, 65(3):479-491.
24. Ottaviani J.I., Kwik-Uribe C., Keen C.L., Schroeter H. Intake of dietary procyanidins does not contribute to the pool of circulating flavanols in humans. The American Journal of Clinical Nutrition 2012, 95(4):851-858.
25. Pal S., Ho N., Santos C., Dubois P., Mamo J., Croft K., et al. Red wine polyphenolics increase LDL receptor expression and activity and suppress the secretion of ApoB100 from human HepG2 cells. The Journal of Nutrition 2003, 133(3):700-706.
26. Pill J., Aufenanger J., Stegmeier K., Schmidt F.H., Müller D. Thin-layer chromatography of radioactively labelled cholesterol and precursors from biological material. Fresenius' Zeitschrift Für Analytische Chemie 1987, 327(5-6):558-560.
27. Prasain J.K., Peng N., Dai Y., Moore R., Arabshahi A., Wilson L., et al. Liquid chromatography tandem mass spectrometry identification of proanthocyanidins in rat plasma after oral administration of grape seed extract. Phytomedicine 2009, 16(2):233-243.
28. Quesada H., del Bas J.M., Pajuelo D., Díaz S., Fernandez-Larrea J., Pinent M., et al. Grape seed proanthocyanidins correct dyslipidemia associated with a high-fat diet in rats and repress genes controlling lipogenesis and VLDL assembling in liver. International Journal of Obesity 2009, 33:1007-1012. (2005).
29. Quiñones M., Guerrero L., Suarez M., Pons Z., Aleixandre A., Arola L., et al. Low-molecular procyanidin rich grape seed extract exerts antihypertensive effect in males spontaneously hypertensive rats. Food Research International 2013, 51(2):587-595.
30. Rasmussen S.E., Frederiksen H., Struntze Krogholm K., Poulsen L. Dietary proanthocyanidins: occurrence, dietary intake, bioavailability, and protection against cardiovascular disease. Molecular Nutrition & Food Research 2005, 49(2):159-174.
31. Rice-Evans C. Flavonoid antioxidants. Current Medicinal Chemistry 2001, 8(7):797-807.
32. Serra A., Macià A., Romero M.P., Valls J., Bladé C., Arola L., et al. Bioavailability of procyanidin dimers and trimers and matrix food effects in in vitro and in vivo models. British Journal of Nutrition 2010, 103(07):944-952.
33. Serra A., Macià A., Rubió L., Anglès N., Ortega N., Morelló J.R., et al. Distribution of procyanidins and their metabolites in rat plasma and tissues in relation to ingestion of procyanidin-enriched or procyanidin-rich cocoa creams. European Journal of Nutrition 2013, 52(3):1029-1038.
34. Shivashankara K.S., Acharya S.N. Bioavailability of dietary polyphenols and the cardiovascular diseases. The Open Nutraceuticals Journal 2010, 3:227-241.
35. Tomas-Barberan F.A., Cienfuegos-Jovellanos E., Marín A., Muguerza B., Gil-Izquierdo A., Cerda B., et al. A new process to develop a cocoa powder with higher flavonoid monomer content and enhanced bioavailability in healthy humans. Journal of Agricultural and Food Chemistry 2007, 55(10):3926-3935.
36. Vinson J.A., Teufel K., Wu N. Red wine, dealcoholized red wine, and especially grape juice, inhibit atherosclerosis in a hamster model. Atherosclerosis 2001, 156(1):67-72.
37. Wang X., Hasegawa J., Kitamura Y., Wang Z., Matsuda A., Shinoda W., et al. Effects of hesperidin on the progression of hypercholesterolemia and fatty liver induced by high-cholesterol diet in rats. Journal of Pharmacological Sciences 2011, 117(3):129-138.
38. Yang Y., Piao X., Zhang M., Wang X., Xu B., Zhu J., et al. Bioactivity-guided fractionation of the triglyceride-lowering component and in vivo and in vitro evaluation of hypolipidemic effects of Calyx seu fructus physalis. Lipids in Health and Disease 2012, 11(1):38-45.